Medical management of male infertility in the absence of a specific etiology

Seminars in Reproductive Medicine

Volumn 32, Issue 4, 2014, Pages 313-318

  Gudeloglu, Ahmet ^a   Brahmbhatt, Jamin V ^b   Parekattil, Sijo J ^b  

^a Personalized Urology and Robotics   (Turkey)

^b South Lake Hospital   (United States)

Author keywords

anastrozole; antiestrogens; antioxidants; aromatase inhibitors; carnitine; clomiphene; empirical medical treatment; gonadotropins; idiopathic male infertility; lycopene

Indexed keywords

ALPHA TOCOPHEROL; ANASTROZOLE; ANTIESTROGEN; AROMATASE INHIBITOR; CARNITINE; CHORIONIC GONADOTROPIN; CLOMIFENE; FERTILITY PROMOTING AGENT; FOLLITROPIN; GLUTATHIONE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; LUTEINIZING HORMONE; LYCOPENE; SELENIUM; TAMOXIFEN; TESTOLACTONE; TESTOSTERONE;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; ENDOCRINE FUNCTION; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYPOTHALAMIC PITUITARY TESTICULAR AXIS; IDIOPATHIC DISEASE; IDIOPATHIC MALE INFERTILITY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE INFERTILITY; PHARMACEUTICAL CARE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPERMATOGENESIS; SYSTEMATIC REVIEW (TOPIC); TESTOSTERONE BLOOD LEVEL; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FEMALE; FERTILITY; INFERTILITY, MALE; PATHOPHYSIOLOGY; PREGNANCY; RISK FACTOR; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY; FERTILITY AGENTS; HUMANS; INFERTILITY, MALE; MALE; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84902375552     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1375184     Document Type: Article

References (66)

1. Jungwirth A., Giwercman A., Tournaye H., et al. European Association of Urology Working Group on Male Infertility. European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol: 2012; 62 2 324 332
2. Hamada A., Esteves S. C., Nizza M., Agarwal A. Unexplained male infertility: diagnosis and management. Int Braz J Urol: 2012; 38 5 576 594
3. Schiff J. D., Ramírez M. L., Bar-Chama N. Medical and surgical management male infertility. Endocrinol Metab Clin North Am: 2007; 36 2 313 331 (Pubitemid 46817884)
4. Kumar R., Gautam G., Gupta N. P. Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol: 2006; 176 4, Pt 1 1307 1312 (Pubitemid 44307189)
5. Ko E. Y., Siddiqi K., Brannigan R. E., Sabanegh E. S. Jr. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol: 2012; 187 3 973 978
6. Ruwanpura S. M., McLachlan R. I., Meachem S. J. Hormonal regulation of male germ cell development. J Endocrinol: 2010; 205 2 117 131
7. Jungck E. C., Roy S., Greenblatt R. B., Mahesh V. B. Effect of clomiphene citrate on spermatogenesis in the human. a preliminary report. Fertil Steril: 1964; 15 40 43
8. Willets A. E., Corbo J. M., Brown J. N. Clomiphene for the treatment of male infertility. Reprod Sci: 2013; 20 7 739 744
9. Wang C., Chan C. W., Wong K. K., Yeung K. K. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril: 1983; 40 3 358 365 (Pubitemid 13000574)
10. Foss G. L., Tindall V. R., Birkett J. P. The treatment of subfertile men with clomiphene citrate. J Reprod Fertil: 1973; 32 1 167 170
11. World Health Organization A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl: 1992; 15 4 299 307
12. Vandekerckhove P., Lilford R., Vail A., Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev: 2000; 2 CD000151
13. Patankar S. S., Kaore S. B., Sawane M. V., Mishra N. V., Deshkar A. M. Effect of clomiphene citrate on sperm density in male partners of infertile couples. Indian J Physiol Pharmacol: 2007; 51 2 195 198 (Pubitemid 47262287)
14. Ghanem H., Shaeer O., El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril: 2010; 93 7 2232 2235
15. Moradi M., Moradi A., Alemi M., et al. Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: a comparative study. Urol J: 2010; 7 3 188 193
16. Kotoulas I. G., Cardamakis E., Michopoulos J., Mitropoulos D., Dounis A. Tamoxifen treatment in male infertility. I. Effect on spermatozoa. Fertil Steril: 1994; 61 5 911 914 (Pubitemid 24136859)
17. Kadioglu T. C., Köksal I. T., Tunç M., Nane I., Tellaloglu S. Treatment of idiopathic and postvaricocelectomy oligozoospermia with oral tamoxifen citrate. BJU Int: 1999; 83 6 646 648 (Pubitemid 29164302)
18. Miyagawa Y., Tsujimura A., Matsumiya K., et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol: 2005; 173 6 2072 2075 (Pubitemid 40675246)
19. Ishikawa T., Ooba T., Kondo Y., Yamaguchi K., Fujisawa M. Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril: 2007; 88 6 1697 1699 (Pubitemid 350225704)
20. Warne D. W., Decosterd G., Okada H., Yano Y., Koide N., Howles C. M. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril: 2009; 92 2 594 604
21. Homonnai Z. T., Peled M., Paz G. F. Changes in semen quality and fertility in response to endocrine treatment of subfertile men. Gynecol Obstet Invest: 1978; 9 5 244 255 (Pubitemid 9174380)
22. Chehval M. J., Mehan D. J. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril: 1979; 31 6 666 668 (Pubitemid 9166609)
23. Attia A. M., Al-Inany H. G., Proctor M. L. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev: 2006; 1 CD005071
24. Valenti D., La Vignera S., Condorelli R. A., et al. Follicle-stimulating hormone treatment in normogonadotropic infertile men. Nat Rev Urol: 2013; 10 1 55 62
25. Schlegel P. N. Aromatase inhibitors for male infertility. Fertil Steril: 2012; 98 6 1359 1362
26. Clark R. V., Sherins R. J. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl: 1989; 10 3 240 247 (Pubitemid 19163597)
27. Cavallini G., Beretta G., Biagiotti G. Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH. Asian J Androl: 2011; 13 6 895 897
28. Kefer J. C., Agarwal A., Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol: 2009; 16 5 449 457
29. Aitken R. J., Clarkson J. S., Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod: 1989; 41 1 183 197 (Pubitemid 19246344)
30. Henkel R., Kierspel E., Stalf T., et al. Effect of reactive oxygen species produced by spermatozoa and leukocytes on sperm functions in non-leukocytospermic patients. Fertil Steril: 2005; 83 3 635 642 (Pubitemid 40348575)
31. Agarwal A., Saleh R. A., Bedaiwy M. A. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril: 2003; 79 4 829 843 (Pubitemid 36385000)
32. Ryan T. C., Weil G. J., Newburger P. E., Haugland R., Simons E. R. Measurement of superoxide release in the phagovacuoles of immune complex-stimulated human neutrophils. J Immunol Methods: 1990; 130 2 223 233 (Pubitemid 20217331)
33. Kao S. H., Chao H. T., Chen H. W., Hwang T. I., Liao T. L., Wei Y. H. Increase of oxidative stress in human sperm with lower motility. Fertil Steril: 2008; 89 5 1183 1190 (Pubitemid 351671728)
34. de Lamirande E., Lamothe G. Reactive oxygen-induced reactive oxygen formation during human sperm capacitation. Free Radic Biol Med: 2009; 46 4 502 510
35. Ross C., Morriss A., Khairy M., et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online: 2010; 20 6 711 723
36. Tremellen K. Oxidative stress and male infertility-a clinical perspective. Hum Reprod Update: 2008; 14 3 243 258 (Pubitemid 351566975)
37. Young S. S., Eskenazi B., Marchetti F. M., Block G., Wyrobek A. J. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod: 2008; 23 5 1014 1022 (Pubitemid 351757312)
38. Mellinger R. C., Thompson R. J. The effect of clomiphene citrate in male infertility. Fertil Steril: 1966; 17 1 94 103
39. Reuter S. E., Evans A. M. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet: 2012; 51 9 553 572
40. Palmero S., Bottazzi C., Costa M., Leone M., Fugassa E. Metabolic effects of L-carnitine on prepubertal rat Sertoli cells. Horm Metab Res: 2000; 32 3 87 90 (Pubitemid 30202923)
41. Casillas E. R., Villalobos P., Gonzales R. Distribution of carnitine and acylcarnitine in the hamster epididymis and in epididymal spermatozoa during maturation. J Reprod Fertil: 1984; 72 1 197 201 (Pubitemid 14064070)
42. Matalliotakis I., Koumantaki Y., Evageliou A., Matalliotakis G., Goumenou A., Koumantakis E. L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality. Int J Fertil Womens Med: 2000; 45 3 236 240 (Pubitemid 30470182)
43. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J: 1992; 123 6 1726 1727
44. Menchini-Fabris G. F., Canale D., Izzo P. L., Olivieri L., Bartelloni M. Free L-carnitine in human semen: its variability in different andrologic pathologies. Fertil Steril: 1984; 42 2 263 267 (Pubitemid 14093050)
45. Zöpfgen A., Priem F., Sudhoff F., et al. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population. Hum Reprod: 2000; 15 4 840 845 (Pubitemid 30192732)
46. Kohengkul S., Tanphaichitr V., Muangmun V., Tanphaichitr N. Levels of L-carnitine and L-O-acetylcarnitine in normal and infertile human semen: a lower level of L-O-acetylcarnitine in infertile semen. Fertil Steril: 1977; 28 12 1333 1336 (Pubitemid 8257801)
47. Lenzi A., Sgrò P., Salacone P., et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril: 2004; 81 6 1578 1584 (Pubitemid 38749002)
48. Sigman M., Glass S., Campagnone J., Pryor J. L. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril: 2006; 85 5 1409 1414
49. Cavallini G., Ferraretti A. P., Gianaroli L., Biagiotti G., Vitali G. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl: 2004; 25 5 761 770, discussion 771-772 (Pubitemid 39096312)
50. Balercia G., Regoli F., Armeni T., Koverech A., Mantero F., Boscaro M. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril: 2005; 84 3 662 671 (Pubitemid 41317725)
51. Cavallini G., Magli M. C., Crippa A., Ferraretti A. P., Gianaroli L. Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. Asian J Androl: 2012; 14 4 591 598
52. Najm W., Lie D. Dietary supplements commonly used for prevention. Prim Care: 2008; 35 4 749 767
53. Magri V., Trinchieri A., Perletti G., Marras E. Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. Arch Ital Urol Androl: 2008; 80 2 65 78 (Pubitemid 351951363)
54. Hwang E. S., Bowen P. E. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors: 2005; 23 2 97 105 (Pubitemid 41330500)
55. Mendiola J., Torres-Cantero A. M., Vioque J., et al. A low intake of antioxidant nutrients is associated with poor semen quality in patients attending fertility clinics. Fertil Steril: 2010; 93 4 1128 1133
56. Gupta N. P., Kumar R. Lycopene therapy in idiopathic male infertility-a preliminary report. Int Urol Nephrol: 2002; 34 3 369 372 (Pubitemid 36896222)
57. Goyal A., Chopra M., Lwaleed B. A., Birch B., Cooper A. J. The effects of dietary lycopene supplementation on human seminal plasma. BJU Int: 2007; 99 6 1456 1460 (Pubitemid 47164808)
58. Meister A., Anderson M. E. Glutathione. Annu Rev Biochem: 1983; 52 711 760 (Pubitemid 13030692)
59. Lenzi A., Lombardo F., Gandini L., Culasso F., Dondero F. Glutathione therapy for male infertility. Arch Androl: 1992; 29 1 65 68
60. Lenzi A., Picardo M., Gandini L., et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod: 1994; 9 11 2044 2050 (Pubitemid 24354448)
61. Meybodi A. M., Mozdarani H., Moradi ShZ, Akhoond M. R. Importance of sperm gluthatione treatment in ART. J Assist Reprod Genet: 2012; 29 7 625 630
62. Agarwal A., Sekhon L. H. The role of antioxidant therapy in the treatment of male infertility. Hum Fertil (Camb): 2010; 13 4 217 225
63. Kessopoulou E., Powers H. J., Sharma K. K., et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril: 1995; 64 4 825 831
64. Suleiman S. A., Ali M. E., Zaki Z. M., el-Malik E. M., Nasr M. A. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl: 1996; 17 5 530 537 (Pubitemid 26403614)
65. Keskes-Ammar L., Feki-Chakroun N., Rebai T., et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl: 2003; 49 2 83 94 (Pubitemid 36269762)
66. Moslemi M. K., Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate. Int J Gen Med: 2011; 4 99 104